Robert Ang Vor Biopharma Inc. (VOR) insider trading activity

Robert Ang is PRESIDENT AND CEO of Vor Biopharma Inc.. Currently has a direct ownership of 918,952 shares of VOR, which is worth approximately $1.26 Million. The most recent transaction as insider was on Feb 06, 2025, when has been sold 2,787 shares (Common Stock) at a price of $1.5 per share, resulting in proceeds of $4,180. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 919K

16.69% 3M change

10.97% 12M change

Total Value Held $1.26 Million

ROBERT ANG Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 06 2025	SELL Payment of exercise price or tax liability	$4,180 $1.5 p/Share	2,787 Reduced 0.3%	918,952 Common Stock
Feb 03 2025	SELL Payment of exercise price or tax liability	$4,352 $1.34 p/Share	3,248 Reduced 0.41%	784,239 Common Stock
Feb 03 2025	BUY Grant, award, or other acquisition	-	137,500 Added 12.98%	921,739 Common Stock
Nov 06 2024	SELL Payment of exercise price or tax liability	$2,030 $0.86 p/Share	2,361 Reduced 0.3%	787,487 Common Stock
Nov 01 2024	SELL Payment of exercise price or tax liability	$2,200 $0.8 p/Share	2,751 Reduced 0.35%	789,848 Common Stock
Sep 03 2024	SELL Payment of exercise price or tax liability	$10,505 $0.83 p/Share	12,657 Reduced 1.57%	792,599 Common Stock
Aug 06 2024	SELL Payment of exercise price or tax liability	$2,054 $0.87 p/Share	2,361 Reduced 0.29%	805,256 Common Stock
Aug 01 2024	SELL Payment of exercise price or tax liability	$2,585 $0.94 p/Share	2,751 Reduced 0.34%	807,617 Common Stock
May 06 2024	SELL Payment of exercise price or tax liability	$4,131 $1.75 p/Share	2,361 Reduced 0.29%	810,368 Common Stock
May 01 2024	SELL Payment of exercise price or tax liability	$4,869 $1.77 p/Share	2,751 Reduced 0.34%	812,729 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$28,731 $2.27 p/Share	12,657 Reduced 1.53%	815,480 Common Stock
Feb 06 2024	SELL Payment of exercise price or tax liability	$6,468 $2.32 p/Share	2,788 Reduced 0.34%	828,137 Common Stock
Jan 29 2024	BUY Grant, award, or other acquisition	-	150,000 Added 15.29%	830,925 Common Stock
Nov 06 2023	SELL Payment of exercise price or tax liability	$4,297 $1.82 p/Share	2,361 Reduced 0.35%	680,925 Common Stock
Sep 01 2023	SELL Payment of exercise price or tax liability	$33,794 $2.67 p/Share	12,657 Reduced 1.82%	683,286 Common Stock
Aug 07 2023	SELL Payment of exercise price or tax liability	$6,303 $2.67 p/Share	2,361 Reduced 0.34%	695,943 Common Stock
May 08 2023	SELL Payment of exercise price or tax liability	$9,774 $4.14 p/Share	2,361 Reduced 0.34%	698,304 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$69,740 $5.51 p/Share	12,657 Reduced 1.77%	700,665 Common Stock
Feb 06 2023	BUY Grant, award, or other acquisition	-	128,750 Added 15.29%	713,322 Common Stock
Sep 13 2022	BUY Grant, award, or other acquisition	-	172,500 Added 22.79%	584,572 Common Stock

Robert Ang

PRESIDENT AND CEO

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VOR shares.

Notify only if

Value

Insider Trading

Get notified when an Vor Biopharma Inc. insider buys or sells VOR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vor Biopharma Inc.

Track Activities on VOR

Account